High-affinity-receptor-mediated uptake and degradation of glucose-modified proteins: a potential mechanism for the removal of senescent macromolecules.
about
Advanced glycation end products are eliminated by scavenger-receptor-mediated endocytosis in hepatic sinusoidal Kupffer and endothelial cellsAdvanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cellsbeta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosisOrally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathyStudies on the ADP-ribose pyrophosphatase subfamily of the nudix hydrolases and tentative identification of trgB, a gene associated with tellurite resistance.Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE)Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): a new member of the AGE-receptor complexDiabetes and mass spectrometry.Receptors for advanced glycosylation endproducts in human brain: role in brain homeostasisAdvanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging.Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy.Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleuHuman and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathy.Age-related normalization of the browning rate of collagen in diabetic subjects without retinopathy.Macrophage/monocyte receptor for nonenzymatically glycosylated protein is upregulated by cachectin/tumor necrosis factorReceptor-specific induction of insulin-like growth factor I in human monocytes by advanced glycosylation end product-modified proteins.Role of glycation in aging.Endothelial dysfunction as a predictor of cardiovascular disease in type 1 diabetes.Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats.Effect of Type 2 Diabetes Mellitus and Diabetic Nephropathy on IgG Pharmacokinetics and Subcutaneous Bioavailability in the RatModification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency.Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody.Advanced glycosylation endproducts block the antiproliferative effect of nitric oxide. Role in the vascular and renal complications of diabetes mellitus.Rous-Whipple Award Lecture. Atherosclerosis: a defense mechanism gone awry.Immunohistochemical localization of advanced glycosylation end products in coronary atheroma and cardiac tissue in diabetes mellitus.Transposition of an Alu-containing element induced by DNA-advanced glycosylation endproductsOxidative stress and neurodegeneration.Novel macrophage receptor for glucose-modified proteins is distinct from previously described scavenger receptors.Murine macrophages and pancreatic beta cells. Chemotactic properties of insulin and beta-cytostatic action of interleukin 1.Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties.Advanced glycosylation endproducts on erythrocyte cell surface induce receptor-mediated phagocytosis by macrophages. A model for turnover of aging cells.Lipid advanced glycosylation: pathway for lipid oxidation in vivoAGE restriction in diabetes mellitus: a paradigm shift.Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins.Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging.Advanced glycation end products increase retinal vascular endothelial growth factor expression.Advanced glycation end products and diabetic retinopathy.Baking, ageing, diabetes: a short history of the Maillard reaction.Mechanisms of distal axonal degeneration in peripheral neuropathies.Abundance matters: role of albumin in diabetes, a proteomics perspective.
P2860
Q24530074-9713FC6D-3626-4FB8-BC2F-A5FCC223568DQ24563997-3EFA4C52-BB17-486B-91DA-0B3A3F011710Q24597379-34ECD485-04C6-47E8-9B05-67A9D16976B7Q24682750-4A9D8101-B1A7-41A3-BD8B-91A5F90A00CCQ27934562-1E0D7C1C-C091-44F2-93FF-930F9F993800Q28366662-116DB008-FEFE-46B5-900F-79E829303221Q28577438-E3ACF60C-ADCF-41E3-8328-39B8093213F7Q30986952-21F2F0A1-C0A7-40E2-BA96-01DCB4F95743Q32085442-CDF847F5-6415-4818-BFA0-7D00304DA6CAQ33901974-9983BA5D-809C-4A87-82CB-0A53B93E9391Q34111608-7A0E5BF4-6BD3-49AC-B1A2-D514DB017C21Q34124460-DD7B7AA3-510C-4E37-BACB-0B7235788D91Q34504995-0B048233-673F-4985-BE84-58A828B5739FQ34539586-F47689FA-52AD-4C93-ADF4-12FB4B5DF48BQ34580805-D632011D-5A0E-4552-866D-827051E4C192Q35605061-904AE4ED-2B9A-4E73-9524-82B5831D7E2FQ35656681-ACDEC84B-3C1E-4791-A775-9CB3A0E552E1Q35691365-D4DDFAF7-9815-43EC-986A-02C48D4F8BD5Q35764706-B6B7BE98-1EE9-4C57-BE33-E14D6DE78394Q35768430-6C394AE7-16D0-41A6-BF9D-75D058EDDC6CQ35788419-38ACD1FB-FFF0-4F78-8520-5AE66CB6DF7EQ35798371-3045ED91-42D8-4E75-8147-DCC9E1A7AB97Q35822678-4E622FF7-0C64-4415-B337-39348D86D21EQ35833262-245C04DA-78E0-4233-912A-68751C3CE78FQ35833696-61EED1E9-53D4-4FC7-8C8C-E162B87B9DDCQ36191126-EEE9D51C-6157-4F95-A94E-DC92FB519CFCQ36203957-8D068E0A-F6E3-4FD9-8BB4-0DB4216D0BE8Q36352988-BE2C48E9-A5B8-48B7-9633-682ACCC815AFQ36354058-2E9B544C-72B7-43F2-8D6C-8A5A944187E5Q36356851-A2E3BDD9-AFBD-49E9-8DF8-CADC72C53346Q36357263-06A0C045-59F5-42E5-9C54-946293511148Q36412583-1A3BA505-DE76-451A-833D-A8F15068363FQ37003623-D0FE52AE-9F79-4F68-BB6F-057490866693Q37308593-3B19D200-12CF-49C4-8BD2-A93DEA72829AQ37363088-A3E28651-667F-4D2E-ABE6-15245A785E8BQ37379211-91637B61-566E-4B0F-AC64-155383B590BBQ38193463-11499FF9-727E-4B34-A61E-1A47D9ADFC0DQ38232036-EAFE9338-0FB6-4E9A-BA4E-B7C565A32AF1Q38330759-C4D2E746-D1E0-4800-943B-5D1DFACFE553Q38660810-A8E061FD-7AEC-45E5-B614-EF94CF4CC166
P2860
High-affinity-receptor-mediated uptake and degradation of glucose-modified proteins: a potential mechanism for the removal of senescent macromolecules.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 1985
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
High-affinity-receptor-mediate ...... l of senescent macromolecules.
@en
High-affinity-receptor-mediate ...... l of senescent macromolecules.
@nl
type
label
High-affinity-receptor-mediate ...... l of senescent macromolecules.
@en
High-affinity-receptor-mediate ...... l of senescent macromolecules.
@nl
prefLabel
High-affinity-receptor-mediate ...... l of senescent macromolecules.
@en
High-affinity-receptor-mediate ...... l of senescent macromolecules.
@nl
P2093
P2860
P921
P356
P1476
High-affinity-receptor-mediate ...... l of senescent macromolecules.
@en
P2093
P2860
P304
P356
10.1073/PNAS.82.17.5588
P407
P577
1985-09-01T00:00:00Z